Contact us to learn more! Schedule a call now (Mon-Fri, 8am to 8pm)

Pregmune Launches IRMA – A Comprehensive Reproductive Immunology Assessment

May 4, 2022 Pregmune Team
From left to right: Antonio Gargiulo, M.D., Andrea Vidali, M.D., CEO of Pregmune

We’d love to thank everyone who showed up to the IRMA launch event on April 27th at Blender Workspace. It was a memorable night. For those of you who couldn’t join us, don’t worry, we’ll hold more fun and informative events in the future.  

At the launch, we heard from Dr. Antonio Gargiulo, a medical professor at Harvard University. He spoke about how “reproductive failure is a growing health crisis.” He recently began to offer immunological assessments and treatments to his patients with great success. According to Dr. Gargiulo, “the immune system is central to pregnancy, and when we treat fertility patients, we can no longer ignore reproductive immunology.”

After Dr. Gargiulo’s talk, we heard from Dr. Andrea Vidali, CEO of Pregmune. He explained why he founded Pregmune and “created IRMA to help simplify and expand access to reproductive immunology testing and treatments.” Dr. Vidali then walked us through an IRMA report and showed us how it has been used successfully in his clinic to help more than a thousand hopeful patients. 

“Reproductive failure is a growing health crisis. The immune system is central to pregnancy, and when we treat fertility patients, we can no longer ignore reproductive immunology.”

– Antonio Gargiulo, MD 

What is IRMA?

IRMA, Pregmune’s first offering, is an AI-powered fertility assessment that guides physicians and their patients through a comprehensive reproductive immunology evaluation. We make it easy to order 55 informative blood tests, then we analyze the test results and present the findings in an easy-to-read, patient-friendly report that includes intuitive visuals and a results-based treatment plan recommendation. 

Free Sample Report

Meet IRMA

See how Pregmune’s comprehensive reproductive immunology assessment is providing answers for patients and their doctors.

Download Sample Report

“We created IRMA to help simplify and expand access to reproductive immunology testing and treatments.”

– Andrea Vidali, MD 

You can check out some highlights of the night below. As you can see, it was a memorable evening.

Don’t hesitate to contact us if you have a medical practice and would like to view a recording of our speakers’ talks and schedule a Q&A session with one of our experts.

We look forward to talking with you soon! 

From left to right: Ester Pescio, COO, Marco Massini, Adviser, Karine Boulianne, CCO, Jasmine D’Alessandro, Clinical Operations Manager

About Pregmune: We’re an innovative reproductive health technology company, built on a solid foundation of data gained from decades of experience and thousands of successful pregnancies. Our team of fertility specialists and scientists are using artificial intelligence to decipher the complexity of the immune system and help patients grow the families of their dreams.

Our first product, IRMA, provides patients and their doctors with a personalized report and evidence-based treatment plan that addresses immunological sources of unexplained infertility, recurrent pregnancy loss, and recurrent implantation failure.